Prognia
Drug Database
🇺🇸US · FDA ApprovedDiscontinuedNDA021729-002

ABILIFY(ARIPIPRAZOLE)

Manufacturer: OTSUKA

FDA Approval: 07/06/2006

Route: ORAL · TABLET, ORALLY DISINTEGRATING

Active Ingredients

ARIPIPRAZOLE 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ABILIFY — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.